Free Trial

NeuroSense Therapeutics (NRSN) SEC Filings & 10K Form

NeuroSense Therapeutics logo
$0.95 -0.04 (-4.05%)
(As of 02:00 PM ET)

Recent NeuroSense Therapeutics SEC Filings

DateFilerForm TypeView
10/31/2024
3:59 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
10/01/2024
5:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
09/30/2024
3:53 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
7:05 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/27/2024
7:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/24/2024
8:20 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:42 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
4:24 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:25 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:22 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
6:14 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
05/20/2024
3:16 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form F-1/A
05/20/2024
8:02 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
8:02 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
9:21 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:01 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
04/12/2024
3:30 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
3:30 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B5
04/10/2024
8:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:32 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/08/2024
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

04/05/2024
8:28 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
4:10 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
04/04/2024
3:31 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/04/2024
3:37 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
02/22/2024
7:25 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2024
12:20 PM
Gordon Ariel (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
Form SC 13G/A
02/13/2024
9:14 AM
Ben-Noon Alon (Filed by)
NeuroSense Therapeutics (Subject)
NeuroSense Therapeutics Ltd. (Subject)
Form SC 13G/A
02/07/2024
8:38 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
7:48 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
7:49 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
4:01 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
4:03 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/21/2023
7:45 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2023
3:30 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/14/2023
8:41 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2023
2:00 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/05/2023
2:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/05/2023
7:01 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2023
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
12/04/2023
5:17 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
11/28/2023
8:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2023
9:36 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRSN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners